{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:47:03Z","timestamp":1792424823453,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Carbapenem-resistant hypervirulent\n                      <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                      (CR-HvKP) poses a critical global health threat. However, molecular epidemiological data on CR-HvKP in Western China remain scarce. This study aimed to characterize the clinical profiles, molecular features, and risk factors of CR-HvKP isolates in Western China.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Sixty-eight carbapenem-resistant\n                      <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                      (CRKP) clinical isolates were collected from January to December in 2024. Clinical characterization included antimicrobial susceptibility profiling and hypermucoviscosity assessment via string test. Detection of carbapenemases using inhibitor enhancement test. Molecular characteristics of CRKP included serotype, carbapenemases, virulence-associated factors, and multilocus sequence typing (MLST) performed by using the PCR method. CR-HvKP was defined as the presence of any one of\n                      <jats:italic>rmpA<\/jats:italic>\n                      ,\n                      <jats:italic>rmpA2<\/jats:italic>\n                      ,\n                      <jats:italic>iroB<\/jats:italic>\n                      ,\n                      <jats:italic>iucA<\/jats:italic>\n                      , and\n                      <jats:italic>peg-344<\/jats:italic>\n                      . Risk factors were initially evaluated using univariate logistic regression analysis, with significant variables subsequently incorporated into a multivariate regression model. A\n                      <jats:italic>p<\/jats:italic>\n                      -value\u2009&lt;\u20090.05 was considered statistically significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 68 CRKP isolates, 36 were identified as CR-HvKP, all harboring the\n                      <jats:italic>iucA<\/jats:italic>\n                      gene (100%, 36\/36). However, only 22.2% (8\/36) of string test results correlated with virulence gene presence. All CRKP strains exhibited high resistance to most antibiotics, with comparatively lower resistance rates observed for tigecycline (0%) and polymyxin B (14.7%). Carbapenemase production was the predominant resistance mechanism, with 61.8% (42\/68) carrying\n                      <jats:italic>bla<\/jats:italic>\n                      <jats:sub>KPC\u22122<\/jats:sub>\n                      . Serotyping and MLST revealed that ST11-KL64 CR-HvKP being predominant. A novel\n                      <jats:italic>wzi752<\/jats:italic>\n                      allele was identified, encoding amino acid sequences homologous to serotype KL47. Univariate analysis demonstrated significantly higher ICU admission rates (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.018) and carbapenem exposure (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.023) in CR-HvKP patients with infections. Multivariate analysis highlighted borderline significance for ICU admission (OR\u2009=\u20092.939,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.056) as a potential risk factor.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The ST11-KL64 CR-HvKP clone harboring\n                      <jats:italic>bla<\/jats:italic>\n                      <jats:sub>KPC\u22122<\/jats:sub>\n                      and\n                      <jats:italic>iucA<\/jats:italic>\n                      has emerged as a dominant pathogen of hospital infections in Western China, posing dual threats of resistance and virulence. Enhanced molecular surveillance and infection control strategies are urgently needed to mitigate its spread.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-11241-6","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:31:48Z","timestamp":1751362308000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Emergence of ST11-KL64 carbapenem-resistant hypervirulent Klebsiella Pneumoniae isolates harboring blaKPC\u22122 and iucA from a tertiary teaching hospital in Western China"],"prefix":"10.1186","volume":"25","author":[{"given":"Haojun","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiurong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"2","key":"11241_CR1","doi-asserted-by":"publisher","first-page":"ofad649","DOI":"10.1093\/ofid\/ofad649","volume":"11","author":"XC Lin","year":"2024","unstructured":"Lin XC, Li CL, Zhang SY, Yang X F,Jiang M. The global and regional prevalence of Hospital-Acquired Carbapenem-Resistant Klebsiella pneumoniae infection: A systematic review and Meta-analysis. Open Forum Infect Dis. 2024;11(2):ofad649.","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"11241_CR2","doi-asserted-by":"publisher","first-page":"e00693","DOI":"10.1128\/IAI.00693-20","volume":"89","author":"S Gonzalez-Ferrer","year":"2021","unstructured":"Gonzalez-Ferrer S, Pe\u00f1aloza HF, Budnick JA, Bain WG, Nordstrom HR, Lee JS, et al. Finding order in the chaos: outstanding questions in Klebsiella pneumoniae pathogenesis. Infect Immun. 2021;89(4):e00693\u201300620.","journal-title":"Infect Immun"},{"key":"11241_CR3","unstructured":"World Health Organization. 2024. Disease Outbreak News; Antimicrobial Resistance, Hypervirulent Klebsiella pneumoniae - Global situation. Available at: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2024-DON527"},{"key":"11241_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fpubh.2019.00229","volume":"7","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Zhang X, Torres VVL, Liu H, Rocker A, Zhang Y, et al. An outbreak of Carbapenem-Resistant and hypervirulent Klebsiella pneumoniae in an intensive care unit of a major teaching hospital in wenzhou, China. Front Public Health. 2019;7:229.","journal-title":"Front Public Health"},{"issue":"1","key":"11241_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/21505594.2020.1859274","volume":"12","author":"F Morales-Le\u00f3n","year":"2021","unstructured":"Morales-Le\u00f3n F, Opazo-Capurro A, Caro C, Lincopan N, Cardenas-Arias A, Esposito F, et al. Hypervirulent and hypermucoviscous extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae and Klebsiella variicola in Chile. Virulence. 2021;12(1):35\u201344.","journal-title":"Virulence"},{"issue":"9","key":"11241_CR6","doi-asserted-by":"publisher","first-page":"e00959","DOI":"10.1128\/JCM.00959-18","volume":"56","author":"S Harada","year":"2018","unstructured":"Harada S, Doi Y. Hypervirulent Klebsiella pneumoniae: a call for consensus definition and international collaboration. J Clin Microbiol. 2018;56(9):e00959\u201318.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"11241_CR7","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1080\/22221751.2022.2049458","volume":"11","author":"X Yang","year":"2022","unstructured":"Yang X, Sun Q, Li J, Jiang Y, Li Y, Lin J, et al. Molecular epidemiology of carbapenem-resistant hypervirulent Klebsiella pneumoniae in China. Emerg Microbes Infect. 2022;11(1):841\u20139.","journal-title":"Emerg Microbes Infect"},{"issue":"9","key":"11241_CR8","doi-asserted-by":"publisher","first-page":"e00776","DOI":"10.1128\/JCM.00776-18","volume":"56","author":"TA Russo","year":"2018","unstructured":"Russo TA, Olson R, Fang CT, Stoesser N, Miller M, MacDonald U, et al. Identification of biomarkers for differentiation of hypervirulent Klebsiella pneumoniae from classical K. pneumoniae. J Clin Microbiol. 2018;56(9):e00776\u201318.","journal-title":"J Clin Microbiol"},{"key":"11241_CR9","doi-asserted-by":"publisher","first-page":"1003783","DOI":"10.3389\/fmicb.2022.1003783","volume":"13","author":"YL Han","year":"2022","unstructured":"Han YL, Wen XH, Zhao W, Cao XS, Wen JX, Wang JR, et al. Epidemiological characteristics and molecular evolution mechanisms of carbapenem-resistant hypervirulent Klebsiella pneumoniae. Front Microbiol. 2022;13:1003783.","journal-title":"Front Microbiol"},{"issue":"6","key":"11241_CR10","doi-asserted-by":"publisher","first-page":"e0047722","DOI":"10.1128\/msphere.00477-22","volume":"7","author":"P Xia","year":"2022","unstructured":"Xia P, Yi M, Yuan Y, Huang J, Yang B, Liao J, et al. Coexistence of multidrug resistance and virulence in a single conjugative plasmid from a hypervirulent Klebsiella pneumoniae isolate of sequence type 25. mSphere. 2022;7(6):e0047722.","journal-title":"mSphere"},{"issue":"5","key":"11241_CR11","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.jinf.2015.07.010","volume":"71","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Zeng J, Liu W, Zhao F, Hu Z, Zhao C, et al. Emergence of a hypervirulent carbapenem-resistant Klebsiella pneumoniae isolate from clinical infections in China. J Infect. 2015;71(5):553\u201360.","journal-title":"J Infect"},{"issue":"1","key":"11241_CR12","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1080\/22221751.2020.1721334","volume":"9","author":"Q Yang","year":"2020","unstructured":"Yang Q, Jia X, Zhou M, Zhang H, Yang W, Kudinha T, et al. Emergence of ST11-K47 and ST11-K64 hypervirulent carbapenem-resistant Klebsiella pneumoniae in bacterial liver abscesses from china: a molecular, biological, and epidemiological study. Emerg Microbes Infect. 2020;9(1):320\u201331.","journal-title":"Emerg Microbes Infect"},{"issue":"2","key":"11241_CR13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/jac\/dkz446","volume":"75","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Jin L, Ouyang P, Wang Q, Wang R, Wang J, et al. Evolution of hypervirulence in carbapenem-resistant Klebsiella pneumoniae in china: a multicentre, molecular epidemiological analysis. J Antimicrob Chemother. 2020;75(2):327\u201336.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"11241_CR14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jmii.2023.10.012","volume":"57","author":"MQ Guo","year":"2024","unstructured":"Guo MQ, Wang YT, Wang SS, Chen LK, Xu YH, Li G. Genomic epidemiology of hypervirulent carbapenem-resistant Klebsiella pneumoniae at Jinshan local hospital, shanghai, during 2014\u20132018. J Microbiol Immunol Infect. 2024;57(1):128\u201337.","journal-title":"J Microbiol Immunol Infect"},{"key":"11241_CR15","doi-asserted-by":"publisher","first-page":"120263","DOI":"10.1016\/j.watres.2023.120263","volume":"242","author":"H Zou","year":"2023","unstructured":"Zou H, Zhou Z, Berglund B, Zheng B, Meng M, Zhao L, et al. Persistent transmission of carbapenem-resistant, hypervirulent Klebsiella pneumoniae between a hospital and urban aquatic environments. Water Res. 2023;242:120263.","journal-title":"Water Res"},{"issue":"1","key":"11241_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12941-024-00711-5","volume":"23","author":"R Mohammed","year":"2024","unstructured":"Mohammed R, Nader SM, Hamza D, A,Sabry MA. Occurrence of carbapenem-resistant hypervirulent Klebsiella pneumoniae in oysters in egypt: a significant public health issue. Ann Clin Microbiol Antimicrob. 2024;23(1):53.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"11241_CR17","volume-title":"Performance standards for antimicrobial susceptibility testing. CLSI supplement M100","author":"Clinical and Laboratory Standards Institute","year":"2023","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. CLSI supplement M100. 33rd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2023.","edition":"33"},{"key":"11241_CR18","unstructured":"U.S. Food Drug Administration. 2023. Tigecycline-Injection Products. Available at: https:\/\/www.fda.gov\/drugs\/development-resources\/tigecycline-injection-products."},{"issue":"6","key":"11241_CR19","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s10096-011-1396-6","volume":"31","author":"DK Pomakova","year":"2012","unstructured":"Pomakova DK, Hsiao CB, Beanan JM, Olson R, MacDonald U, Keynan Y, et al. Clinical and phenotypic differences between classic and hypervirulent Klebsiella pneumonia: an emerging and under-recognized pathogenic variant. Eur J Clin Microbiol Infect Dis. 2012;31(6):981\u20139.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"11241_CR20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13756-023-01331-y","volume":"12","author":"L Li","year":"2023","unstructured":"Li L, Li S, Wei X, Lu Z, Qin X, Li M. Infection with Carbapenem-resistant hypervirulent Klebsiella pneumoniae: clinical, virulence and molecular epidemiological characteristics. Antimicrob Resist Infect Control. 2023;12(1):124.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"12","key":"11241_CR21","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1128\/JCM.01924-13","volume":"51","author":"S Brisse","year":"2013","unstructured":"Brisse S, Passet V, Haugaard AB, Babosan A, Kassis-Chikhani N, Struve C, et al. Wzi gene sequencing, a rapid method for determination of capsular type for Klebsiella strains. J Clin Microbiol. 2013;51(12):4073\u20138.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"11241_CR22","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/molbev\/msy096","volume":"35","author":"S Kumar","year":"2018","unstructured":"Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol. 2018;35(6):1547\u20139.","journal-title":"Mol Biol Evol"},{"issue":"W1","key":"11241_CR23","doi-asserted-by":"publisher","first-page":"W78","DOI":"10.1093\/nar\/gkae268","volume":"52","author":"I Letunic","year":"2024","unstructured":"Letunic I, Bork P. Interactive tree of life (iTOL) v6: recent updates to the phylogenetic tree display and annotation tool. Nucleic Acids Res. 2024;52(W1):W78\u201382.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"11241_CR24","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/bioinformatics\/btw582","volume":"33","author":"M Nascimento","year":"2017","unstructured":"Nascimento M, Sousa A, Ramirez M, Francisco AP, Carri\u00e7o JA, Vaz C. PHYLOViZ 2.0: providing scalable data integration and visualization for multiple phylogenetic inference methods. Bioinformatics. 2017;33(1):128\u20139.","journal-title":"Bioinformatics"},{"key":"11241_CR25","doi-asserted-by":"publisher","first-page":"127839","DOI":"10.1016\/j.micres.2024.127839","volume":"288","author":"TY Lei","year":"2024","unstructured":"Lei TY, Liao BB, Yang LR, Wang Y, Chen XB. Hypervirulent and carbapenem-resistant Klebsiella pneumoniae: A global public health threat. Microbiol Res. 2024;288:127839.","journal-title":"Microbiol Res"},{"key":"11241_CR26","doi-asserted-by":"publisher","first-page":"964290","DOI":"10.3389\/fcimb.2022.964290","volume":"12","author":"M Sohrabi","year":"2022","unstructured":"Sohrabi M, Alizade Naini M, Rasekhi A, Oloomi M, Moradhaseli F, Ayoub A, et al. Emergence of K1 ST23 and K2 ST65 hypervirulent klebsiella pneumoniae as true pathogens with specific virulence genes in cryptogenic pyogenic liver abscesses Shiraz Iran. Front Cell Infect Microbiol. 2022;12:964290.","journal-title":"Front Cell Infect Microbiol"},{"key":"11241_CR27","doi-asserted-by":"publisher","first-page":"765624","DOI":"10.3389\/fpubh.2022.765624","volume":"10","author":"T Wei","year":"2022","unstructured":"Wei T, Zou C, Qin J, Tao J, Yan L, Wang J, et al. Emergence of hypervirulent ST11-K64 Klebsiella pneumoniae poses a serious clinical threat in older patients. Front Public Health. 2022;10:765624.","journal-title":"Front Public Health"},{"key":"11241_CR28","doi-asserted-by":"publisher","first-page":"925440","DOI":"10.3389\/fcimb.2022.925440","volume":"12","author":"J Li","year":"2022","unstructured":"Li J, Tang M, Liu Z, Xia F, Min C, Hu Y, et al. Molecular and clinical characterization of hypervirulent Klebsiella pneumoniae isolates from individuals with urinary tract infections. Front Cell Infect Microbiol. 2022;12:925440.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"11241_CR29","doi-asserted-by":"publisher","first-page":"2306957","DOI":"10.1080\/22221751.2024.2306957","volume":"13","author":"M Xie","year":"2024","unstructured":"Xie M, Ye L, Chen K, Xu Q, Yang C, Chen X, et al. Clinical use of Tigecycline May contribute to the widespread dissemination of carbapenem-resistant hypervirulent Klebsiella pneumoniae strains. Emerg Microbes Infect. 2024;13(1):2306957.","journal-title":"Emerg Microbes Infect"},{"issue":"21","key":"11241_CR30","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1016\/j.scib.2023.09.040","volume":"68","author":"D Pu","year":"2023","unstructured":"Pu D, Zhao J, Chang K, Zhuo X, Cao B. Superbugs with hypervirulence and carbapenem resistance in Klebsiella pneumoniae: the rise of such emerging nosocomial pathogens in China. Sci Bull (Beijing). 2023;68(21):2658\u201370.","journal-title":"Sci Bull (Beijing)"},{"key":"11241_CR31","doi-asserted-by":"publisher","first-page":"709681","DOI":"10.3389\/fcimb.2021.709681","volume":"11","author":"C Shankar","year":"2021","unstructured":"Shankar C, Basu S, Lal B, Shanmugam S, Vasudevan K, Mathur P, et al. Aerobactin seems to be a promising marker compared with unstable RmpA2 for the identification of hypervirulent Carbapenem-Resistant Klebsiella pneumoniae: in Silico and in vitro evidence. Front Cell Infect Microbiol. 2021;11:709681.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"11241_CR32","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1186\/s12866-024-03564-2","volume":"24","author":"HX Hong","year":"2024","unstructured":"Hong HX, Huo BH, Xiang TX, Wei DD, Huang QS, Liu P, et al. Virulence plasmid with IroBCDN deletion promoted cross-regional transmission of ST11-KL64 carbapenem-resistant hypervirulent Klebsiella pneumoniae in central China. BMC Microbiol. 2024;24(1):400.","journal-title":"BMC Microbiol"},{"issue":"5","key":"11241_CR33","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41579-022-00820-y","volume":"21","author":"EM Darby","year":"2023","unstructured":"Darby EM, Trampari E, Siasat P, Gaya MS, Alav I, Webber MA, et al. Molecular mechanisms of antibiotic resistance revisited. Nat Rev Microbiol. 2023;21(5):280\u201395.","journal-title":"Nat Rev Microbiol"},{"key":"11241_CR34","doi-asserted-by":"publisher","first-page":"622280","DOI":"10.3389\/fmicb.2021.622280","volume":"12","author":"QS Huang","year":"2021","unstructured":"Huang QS, Liao W, Xiong Z, Li D, Du FL, Xiang TX, et al. Prevalence of the NTE(KPC)-I on IncF plasmids among hypervirulent Klebsiella pneumoniae isolates in Jiangxi province, South China. Front Microbiol. 2021;12:622280.","journal-title":"Front Microbiol"},{"issue":"10","key":"11241_CR35","doi-asserted-by":"publisher","first-page":"e00779","DOI":"10.1128\/AAC.00779-18","volume":"62","author":"R Xiang","year":"2018","unstructured":"Xiang R, Zhang AY, Ye XL, Kang ZZ, Lei CW, Wang HN. Various sequence types of Enterobacteriaceae isolated from commercial chicken farms in China and carrying the bla(NDM-5) gene. Antimicrob Agents Chemother. 2018;62(10):e00779\u201318.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"11241_CR36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41467-023-44351-3","volume":"15","author":"R Wang","year":"2024","unstructured":"Wang R, Zhang A, Sun S, Yin G, Wu X, Ding Q, et al. Increase in antioxidant capacity associated with the successful subclone of hypervirulent carbapenem-resistant Klebsiella pneumoniae ST11-KL64. Nat Commun. 2024;15(1):67.","journal-title":"Nat Commun"},{"key":"11241_CR37","doi-asserted-by":"publisher","first-page":"1353849","DOI":"10.3389\/fmicb.2024.1353849","volume":"15","author":"F Zhang","year":"2024","unstructured":"Zhang F, Li L, Zhao Y, Dong H, Zhao B, Zhao X, et al. Molecular characterization of hybrid virulence plasmids in ST11-KL64 KPC-2-producing multidrug-resistant hypervirulent Klebsiella pneumoniae from China. Front Microbiol. 2024;15:1353849.","journal-title":"Front Microbiol"},{"key":"11241_CR38","doi-asserted-by":"publisher","first-page":"1325077","DOI":"10.3389\/fmicb.2023.1325077","volume":"14","author":"G Mendes","year":"2023","unstructured":"Mendes G, Santos ML, Ramalho JF, Duarte A, Caneiras C. Virulence factors in carbapenem-resistant hypervirulent Klebsiella pneumoniae. Front Microbiol. 2023;14:1325077.","journal-title":"Front Microbiol"},{"key":"11241_CR39","doi-asserted-by":"publisher","first-page":"1407219","DOI":"10.3389\/fcimb.2024.1407219","volume":"14","author":"Y Tu","year":"2024","unstructured":"Tu Y, Gao H, Zhao R, Yan J, Wu X. Molecular characteristics and pathogenic mechanisms of KPC-3 producing hypervirulent carbapenem-resistant Klebsiella pneumoniae (ST23-K1). Front Cell Infect Microbiol. 2024;14:1407219.","journal-title":"Front Cell Infect Microbiol"},{"key":"11241_CR40","doi-asserted-by":"publisher","first-page":"1464816","DOI":"10.3389\/fcimb.2024.1464816","volume":"14","author":"YQ Lee","year":"2024","unstructured":"Lee YQ, Sri La Sri Ponnampalavanar S, Wong JH, Kong ZX, Ngoi ST, Karunakaran R, et al. Investigation on the mechanisms of carbapenem resistance among the non-carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae. Front Cell Infect Microbiol. 2024;14:1464816.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"11241_CR41","doi-asserted-by":"publisher","first-page":"7962","DOI":"10.1038\/s41467-023-43802-1","volume":"14","author":"TJ Kochan","year":"2023","unstructured":"Kochan TJ, Nozick SH, Valdes A, Mitra SD, Cheung BH, Lebrun-Corbin M, et al. Klebsiella pneumoniae clinical isolates with features of both multidrug-resistance and hypervirulence have unexpectedly low virulence. Nat Commun. 2023;14(1):7962.","journal-title":"Nat Commun"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11241-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11241-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11241-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:31:50Z","timestamp":1751362310000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11241-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11241"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11241-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"14 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. The study protocol and the waiver of informed consent were reviewed and approved by the Ethics Committee of West China School of Public Health and West China Fourth Hospital, Sichuan University (Approval No. 2024258). The waiver was granted because this retrospective study analyzed anonymized bacterial isolates, involved no additional clinical interventions, and strictly protected patient confidentiality through data de-identification.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"880"}}